
1. Open Forum Infect Dis. 2021 Nov 18;8(11):ofab525. doi: 10.1093/ofid/ofab525.
eCollection 2021 Nov.

Crushing and Splitting Direct-Acting Antivirals for Hepatitis C Virus Treatment: 
A Case Series and Literature Review.

Whelchel K(1), Zuckerman AD(1), Koren DE(2), Derrick C(3), Bouchard J(4),
Chastain CA(5).

Author information: 
(1)Specialty Pharmacy Services, Vanderbilt University Medical Center, Nashville, 
Tennessee, USA.
(2)Department of Pharmacy Services, Temple University Health System,
Philadelphia, Pennsylvania, USA.
(3)Department of Infectious Disease, University of South Carolina, Columbia,
South Carolina, USA.
(4)Department of Pharmacy, University of South Carolina, Columbia, South
Carolina, USA.
(5)Division of Infectious Diseases, Department of Medicine, Vanderbilt University
Medical Center, Nashville, Tennessee, USA.

Limited data exist regarding the use of direct-acting antivirals (DAAs) for
hepatitis C virus (HCV) in patients who are unable to swallow tablets. This case 
series describes HCV treatment in patients requiring tablet manipulation,
providing evidence for safety and effectiveness of HCV DAA tablet manipulation.

Â© The Author(s) 2021. Published by Oxford University Press on behalf of
Infectious Diseases Society of America.

DOI: 10.1093/ofid/ofab525 
PMCID: PMC8601046
PMID: 34805439 

